To this point, a recent study that indiscriminately performed MOG-IgG testing in consecutive neurologic patients found that the majority with low antibody levels had non-inflammatory diseases such as stroke, rather than MS (76). The gene discussed is MOG; the disease is myeloid sarcoma.